Varró A - Search Results

1

Peroxynitrite-induced alpha-actinin nitration and contractile alterations in isolated human myocardial cells.

Borbély A, Tóth A, Edes I, Virág L, Papp JG, Varró A, Paulus WJ, van der Velden J, Stienen GJ, Papp Z. Borbély A, et al. Among authors: varro a. Cardiovasc Res. 2005 Aug 1;67(2):225-33. doi: 10.1016/j.cardiores.2005.03.025. Epub 2005 Apr 26. Cardiovasc Res. 2005. PMID: 16005301

2

Interaction of different potassium channels in cardiac repolarization in dog ventricular preparations: role of repolarization reserve.

Biliczki P, Virág L, Iost N, Papp JG, Varró A. Biliczki P, et al. Among authors: varro a. Br J Pharmacol. 2002 Oct;137(3):361-8. doi: 10.1038/sj.bjp.0704881. Br J Pharmacol. 2002. PMID: 12237256 Free PMC article.

3

Low 4-aminopyridine concentration-induced contraction is mediated by neuronal noradrenaline in canine saphenous vein.

Kun A, Pataricza J, Krassói I, Szécsi M, Hohn J, Varró A, Papp JG. Kun A, et al. Among authors: varro a. Vascul Pharmacol. 2002 Jul;39(1-2):7-11. doi: 10.1016/s1537-1891(02)00278-1. Vascul Pharmacol. 2002. PMID: 12616985

4

Comparison of the effect of class IA antiarrhythmic drugs on transmembrane potassium currents in rabbit ventricular myocytes.

Iost N, Virág L, Varró A, Papp JG. Iost N, et al. Among authors: varro a. J Cardiovasc Pharmacol Ther. 2003 Mar;8(1):31-41. doi: 10.1177/107424840300800i106. J Cardiovasc Pharmacol Ther. 2003. PMID: 12652328

5

Endocardial versus epicardial differences in L-type calcium current in canine ventricular myocytes studied by action potential voltage clamp.

Bányász T, Fülöp L, Magyar J, Szentandrássy N, Varró A, Nánási PP. Bányász T, et al. Among authors: varro a. Cardiovasc Res. 2003 Apr 1;58(1):66-75. doi: 10.1016/s0008-6363(02)00853-2. Cardiovasc Res. 2003. PMID: 12667947

6

Multiple cellular electrophysiological effects of azimilide in canine cardiac preparations.

Takács J, Iost N, Lengyel C, Virág L, Nesic M, Varró A, Papp JG. Takács J, et al. Among authors: varro a. Eur J Pharmacol. 2003 Jun 6;470(3):163-70. doi: 10.1016/s0014-2999(03)01792-8. Eur J Pharmacol. 2003. PMID: 12798954

7

Theoretical possibilities for the development of novel antiarrhythmic drugs.

Varró A, Biliczki P, Iost N, Virág L, Hála O, Kovács P, Mátyus P, Papp JG. Varró A, et al. Curr Med Chem. 2004 Jan;11(1):1-11. doi: 10.2174/0929867043456296. Curr Med Chem. 2004. PMID: 14754422 Review.

8

Novel antiarrhythmic compounds with combined class IB and class III mode of action.

Mátyus P, Varga I, Rettegi T, Simay A, Kállay N, Károlyházy L, Kocsis A, Varró A, Pénzes I, Papp JG. Mátyus P, et al. Among authors: varro a. Curr Med Chem. 2004 Jan;11(1):61-9. doi: 10.2174/0929867043456232. Curr Med Chem. 2004. PMID: 14754426 Review.

9

Levosimendan interacts with potassium channel blockers in human saphenous veins.

Höhn J, Pataricza J, Petri A, Tóth GK, Balogh A, Varró A, Papp JG. Höhn J, et al. Among authors: varro a. Basic Clin Pharmacol Toxicol. 2004 Jun;94(6):271-3. doi: 10.1111/j.1742-7843.2004.pto940603.x. Basic Clin Pharmacol Toxicol. 2004. PMID: 15228498 Free article.

10

Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk.

Lengyel C, Dézsi L, Biliczki P, Horváth C, Virág L, Iost N, Németh M, Tálosi L, Papp JG, Varró A. Lengyel C, et al. Among authors: varro a. Br J Pharmacol. 2004 Sep;143(1):152-8. doi: 10.1038/sj.bjp.0705901. Epub 2004 Aug 9. Br J Pharmacol. 2004. PMID: 15302678 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

505 results

Search Page

Filters